News By Tag
* More Tags...
News By Place
Oncology Leads Pharmaceutical Drug Development, reports Kalorama Information
Oncology has emerged as the third largest segment in drug treatment, largely due to the growth of adjunctive therapies and high-cost of effective biotherapy. Sales have increased from $30 billion in 2005 to $65 billion forecasted for 2010.
Drugs in the oncology segment are expected to make a significant impact to current markets, increasing competition and providing advanced alternatives to current therapies. Cancer drugs in development could possibly make up nearly 33% of the potential value.
This is followed by development projects in the areas of cardiovascular and blood; neurotherapeutics;
# # #
About Kalorama Information
Kalorama Information (www.kaloramainformation.com)
Please direct all media inquiries to: